Back to PACB

STATE STREET CORP → PACB

STATE STREET CORP PACB Position History

Pacific Biosciences of California, Inc.

Quarters held
12
Latest value
$10M
Q2 2026
Peak value
$55.2M
First seen
Q4 2023

Dollar value over time

Show data table
PeriodPosition value
Q4 2023$55.2M
Q1 2024$21.6M
Q2 2024$8.1M
Q3 2024$10.7M
Q4 2024$11.8M
Q1 2025$7.5M
Q2 2025$7.1M
Q3 2025$7.6M
Q4 2025$11.1M
Q1 2026$8.1M
Q2 2026$10M
Q2 2026$10M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$10M5.96M——
Q2 2026$10M5.96M——
Q1 2026$8.1M6.12M——
Q4 2025$11.1M5.91M——
Q3 2025$7.6M5.91M——
Q2 2025$7.1M5.75M——
Q1 2025$7.5M6.38M——
Q4 2024$11.8M6.43M——
Q3 2024$10.7M6.28M——
Q2 2024$8.1M5.94M——
Q1 2024$21.6M5.77M——
Q4 2023$55.2M5.62M——

Other funds holding PACB

Other STATE STREET CORP positions

NVDA

NVIDIA CORPORATION

$202B
NVDA

NVIDIA CORPORATION

$202B
NVDA

NVIDIA CORPORATION

$184.9B
NVDA

NVIDIA CORPORATION

$182.9B
AAPL

APPLE INC

$178B
AAPL

APPLE INC

$178B
NVDA

NVIDIA CORPORATION

$173.3B
AAPL

APPLE INC

$164.2B